Based on the pathogenic role of IGFBP7 in degrading the endothelial glycocalyx and aggravating skin inflammation, we further evaluated the possibility of targeting IGFBP7 to treat psoriasis. This evidence concerns the gene IGFBP7 and psoriasis.